Antibody Responses One Year after Mild SARS-CoV-2 Infection
Open Access
- 1 January 2021
- journal article
- research article
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 36 (21), e157
- https://doi.org/10.3346/jkms.2021.36.e157
Abstract
Choe PG, et al. J Korean Med Sci. 2021 May;36(21):e157. https://doi.org/10.3346/jkms.2021.36.e157Keywords
Funding Information
- Seoul National University Hospital (04-2021-0010)
This publication has 10 references indexed in Scilit:
- Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 InfectionEmerging Infectious Diseases, 2021
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersClinical Infectious Diseases, 2021
- Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 InfectionEmerging Infectious Diseases, 2021
- Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral ImmunityImmunity, 2020
- Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic PatientsEmerging Infectious Diseases, 2020
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19The New England Journal of Medicine, 2020
- Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in KoreaThe Korean Journal of Internal Medicine, 2020
- Duration of Antibody Responses after Severe Acute Respiratory SyndromeEmerging Infectious Diseases, 2007